BIO Financial Facts

Net income attributable to Bio-Rad: 31.63M
Weighted average common shares - basic: 28.83M
See Full Income Statement

Cash and cash equivalents: 384.67M
Total assets: 3.47B
See Full Balance Sheet

Bio-Rad Laboratories, Inc. (BIO) Earnings

  |   Expand Research on BIO
Next EPS Date 11/7/14 *Est. EPS Growth Rate -9.2% *Last Qtr.
Average EPS % Beat Rate -44.4% Revenue Growth Rate +2.2% *Last Qtr.
Average % Move 1-Wk after EPS -0.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/5/14 Q214 $1.09$0.95 +$0.14$536.8M$537.58M N/A Details
5/6/14 Q114 $0.23$0.80 -$0.57$509M$515M N/A Details
2/27/14 Q413 $1.51$1.42 +$0.09$602.6M$586.67M N/A Details
11/7/13 Q313 -$0.25$0.91 -$1.16$505.07M$529.02M N/A Details
8/6/13 Q213 $1.20$1.25 -$0.05$525.3M$532.6M N/A Details
5/7/13 Q113 $0.68$1.06 -$0.38$499.7M$506.34M N/A Details
2/26/13 Q412 $1.65$1.34 +$0.31$573.8M$558.68M N/A Details
11/7/12 Q312 $1.48$1.17 +$0.31$498.7M$506.14M N/A Details